Integrated Care in Parkinson's Disease: A Systematic Review andMeta-Analysis

Grants

Funding Acknowledgements

Dr. Rajan receives research grant support from the DST-SERB, DBT, Michael J. Fox Foundation, and All India Institute of Medical Sciences, New Delhi. Dr. Brennan is employed at Genomind and has received consultation fees from Eli Lilly and Signant Health. Prof. Bloem currently serves as associate editor for the Journal of Parkinson's Disease, serves on the editorial of Practical Neurology and Digital Biomarkers, has received honoraria from serving on the scientific advisory board for AbbVie, Biogen, and UCB, has received fees for speaking at conferences from AbbVie, Zambon, Roche, GE Healthcare, and Bial, and has received research support from the Netherlands Organization for Scientific Research, the Michael J. Fox Foundation, UCB, AbbVie, the Stichting Parkinson Fonds, the Hersenstichting Nederland, the Parkinson's Foundation, Verily Life Sciences, Horizon 2020, the Topsector Life Sciences and Health, the Gatsby Foundation, and the Parkinson Vereniging. Dr. Dahodwala has received support from AbbVie (research grant); Roche, Ely Lilly, and Cala Health (clinical trial site investigator); and Acadia (scientific advisory board). Dr. Goldman has received research support from Michael J. Fox Foundation, Parkinson's Foundation; consulting fees from Acadia, Sunovion, Worldwide Med and honoraria from American Academy of Neurology, International Parkinson Disease and Movement Disorder Society, and Parkinson's Foundation. Dr. Grimes has received honorariu, for consulting from the Department of Justice Canada/Government of Canada; clinical trials funding from CIHR, Civitas Therapeutics, Biotie Therapies, and grant funding from CIHR, Parkinson Canada, Ontario Brain Institute, PSI Foundation, Parkinson Research Consortium, uOBMRI. Prof. Kovacs received consultation fees from Hungarian subsidiaries of Medtronic, Abbott, Boston Scientific,. UCB, Krka, and AbbVie. N.K. is supported by the Hungarian Brain Research Program (2017-1.2.1-NKP-2017-00002), NKFIH EFOP3.6.2-16-2017-00008, and NKFIH SNN125143 government-based funds, and the Higher Education Institutional Excellence Programme of the Ministry for Innovation and Technology in Hungary, within the framework of the 5. thematic programs of the University of Pecs. Prof. Iansek has received funding from AbbVie Pharmaceuticals. Dr. Parashos has served as a scientific adviser for DongA and has received research support from AbbVie, DongA, Pharma2B, Impax, Theravance, and Park Nicolet Foundation. Prof. Eggers received payments as a consultant for AbbVie Inc. C.E. received honoraria as a speaker from AbbVie Inc., Daiichi Sankyo Inc., Bayer Vital Inc. C.E. received payments as a consultant for AbbVie Inc. and Philyra Inc.